Re-biopsy patterns among non- small cell lung cancer patients(pats) in Japan: a retrospective study

被引：0
|
作者：
Yoshida, Tatsuya [1 ]
Satouchi, Miyako [2 ]
Kurata, Takayasu [3 ]
Nosaki, Kaname [4 ]
Seto, Takashi [4 ]
机构：
[1] Aichi Canc Ctr, Dept Thorac Oncol, Nagoya, Aichi, Japan
[2] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan
[3] Kansai Med Univ, Hirakata Hosp, Dept Thorac Oncol, Hirakata, Osaka, Japan
[4] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Hirakata, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2-2-4
引用
收藏
页数：2
相关论文
共 50 条
  • [11] THE BRONCHOSCOPY-GUIDED RE-BIOPSY OF NON-SMALL CELL LUNG CANCER IN PATIENTS WHO RELAPSE AFTER GEFITINIB THERAPY
    Okamoto, N.
    Suzuki, H.
    Shiroyama, T.
    Tamiya, M.
    Kitani, M.
    Kurata, K.
    Otsuka, T.
    Yamadori, T.
    Kawahara, K.
    Hirashima, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [12] Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice
    Katsuyuki Hotta
    Kiichiro Ninomiya
    Eiki Ichihara
    Katsuyuki Kiura
    International Journal of Clinical Oncology, 2019, 24 : 41 - 45
  • [13] Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice
    Hotta, Katsuyuki
    Ninomiya, Kiichiro
    Ichihara, Eiki
    Kiura, Katsuyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (01) : 41 - 45
  • [14] Feasibility and Safety of CT-guided Intrathoracic and Bone Re-biopsy for Non-small Cell Lung Cancer
    Matsumoto, Tomohiro
    Hasebe, Terumitsu
    Baba, Yasutaka
    Chosa, Keigo
    Kondo, Shota
    Yamada, Shunsuke
    Yoshimatsu, Rika
    Kubota, Tetsuya
    Fujitaka, Kazunori
    Awai, Kazuo
    Yamagami, Takuji
    ANTICANCER RESEARCH, 2018, 38 (06) : 3587 - 3592
  • [15] Feasibility of Re-Biopsy in Patients with Non-Small Cell Lung Cancer after Failure of Epidermal Growth Factor Receptor Targeted Therapy
    Choi, Yoo-Duk
    Kim, Tae-Ok
    Seo, Hyeong-Won
    Ahn, Sung
    Jang, Jin-Sun
    Park, Cheol-Kyu
    Kim, Young-Chul
    Yun, Ju-Sik
    Song, Sang-Yun
    Na, Kook-Joo
    Yoon, Mee-Sun
    Ahn, Sung-Ja
    Seon, Hyun-Ju
    Kwon, Seong Young
    Oh, In-Jae
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1261 - S1261
  • [16] FEASIBILITY OF RE-BIOPSY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AFTER FAILURE OF EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPY
    Lim, J. H.
    RESPIROLOGY, 2016, 21 : 104 - 104
  • [17] Feasibility Of Re-Biopsy In Patients With Non-Small Cell Lung Cancer After Failure Of Epidermal Growth Factor Receptor Targeted Therapy
    Kim, T.
    Seo, H.
    Jang, J. -S.
    Shin, H. -J.
    Park, C. -K.
    Kwon, Y. -S.
    Kim, Y. -I.
    Lim, S. -C.
    Kim, Y. -C.
    Oh, I. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [18] Re-biopsy for advanced non-small cell lung cancer after EGFR tyrosine kinase inhibitor therapy: CT characteristics of patients with T790M mutation and the use of various re-biopsy procedures
    Koo, H. J.
    Kim, M. Y.
    Choi, C-M.
    Lee, J. C.
    Park, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [19] Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
    Laura Ortega-Granados, Ana
    Artal-Cortes, Angel
    Aguiar-Bujanda, David
    Oramas, Juana
    Luis Firvida, Jose
    De Castro, Javier
    Campillo Fuentes, Juana
    Gordo, Rocio
    Galan, Raquel
    Trigo, Jose
    ANTICANCER RESEARCH, 2019, 39 (03) : 1317 - 1328
  • [20] Should We Re-Biopsy Patients With Lung Cancer Recurrence For Molecular Testing?
    Choi, H. K.
    Feng, Y.
    Keshtgarpour, M.
    Ma, P.
    Almeida, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345